Latest Regulatory News

Page 7 of 798
The ASX has published its latest roster of over 40 entities suspended for more than three months, detailing looming deadlines for overdue reports and trading resumption plans. Failure to meet these could trigger removal from the official list.
Claire Turing
Claire Turing
17 Apr 2026
Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.
Maxwell Dee
Maxwell Dee
17 Apr 2026
Elanor Investors Group has finalised a $125 million recapitalisation with Rockworth Capital Partners, restructuring its debt and setting the stage for expansion in Asia. The move repaid existing facilities and bolstered working capital, while a Singapore acquisition awaits regulatory green light.
Eva Park
Eva Park
17 Apr 2026
Insignia Financial’s $3.3 billion acquisition by CC Capital Partners has cleared its final legal hurdle, with the Federal Court approving the scheme of arrangement and share trading set to suspend imminently. Shareholders on record will receive $4.80 per share when the deal completes later this month.
Claire Turing
Claire Turing
17 Apr 2026
Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.
Victor Sage
Victor Sage
17 Apr 2026
Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.
Ada Torres
Ada Torres
17 Apr 2026
AuKing Mining has agreed to acquire the Tundulu Rare Earths Project in Malawi, a large and under-explored carbonatite complex with strong historical drilling results. The acquisition is supported by a $3 million capital raise to fund exploration and drilling activities.
Maxwell Dee
Maxwell Dee
17 Apr 2026
Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.
Victor Sage
Victor Sage
17 Apr 2026
IRIS Metals has fortified its balance sheet with a A$5.5 million placement and is progressing towards an updated lithium-rubidium resource at Beecher while executing a farm-in deal for a tungsten project in Montana, reinforcing its diversified US critical minerals strategy.
Maxwell Dee
Maxwell Dee
17 Apr 2026
Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.
Ada Torres
Ada Torres
17 Apr 2026
K2 Asset Management has decided to wind down its K2 Australian Small Cap Hedge Fund Complex ETF after a strategic review found it unlikely to meet profitability targets. The closure paves the way for reallocating capital to higher-growth areas and streamlining product offerings.
Claire Turing
Claire Turing
17 Apr 2026
Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.
Maxwell Dee
Maxwell Dee
17 Apr 2026